Vynca key facts
as of Oct 2026- Developer of a health information exchange platform designed to create, store, and share advanced care planning details.
- Vynca is valued at approximately $77.9M as of Oct 2026 (last reported valuation).
- It has raised $50.5M; the latest was Later Stage VC ($5.6M) in Jan 2025.
- Notable investors include MedTech Innovator, StartX (US), First Trust Capital Partners, Equitage Ventures, Link-age Launch — 18 tracked in total.
- Status: Privately Held (backing).
Vynca's last reported valuation, Dec 2021. Nothing priced has surfaced since.
- ·The complete investor list: 18 names
- ·Watch Vynca: the Monday email on marks, rounds and moves
Vynca funding rounds
No funding rounds for Vynca are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Vynca
18+Vynca valuation
Vynca's last reported valuation was $77.9 million in Dec 2021. No priced round, secondary trade or fund mark has surfaced since.
Vynca investors
18 investors are on record for Vynca, including MedTech Innovator, StartX (US), First Trust Capital Partners and Equitage Ventures.
About Vynca
Developer of a health information exchange platform designed to create, store, and share advanced care planning details. The company's platform offers advanced care technology related to health systems, acute care, and post-acute care facilities, along with enhanced care management, and provides patient education and documentation, enabling patients to make end-of-life care choices, manage their ongoing symptoms, and navigate the complex healthcare system.
- Sector
- Healthcare
- HQ
- San Mateo, CA, United States
- Founded
- 2014
- Employees
- 151
- Website
- vyncacare.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.